Alberta Investment Management Corp (AIMCo)’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-71,700	Closed	-$1.29M	–	866
2017 Q4	$1.29M	Hold	71,700	–	–	0.01%	518
2017 Q3	$846K	Hold	71,700	–	–	0.01%	589
2017 Q2	$753K	Hold	71,700	–	–	0.01%	601
2017 Q1	$789K	Buy	+71,700	New	+$832K	0.01%	633

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s SCMP Position: Q1 2018 in Review

Alberta Investment Management Corp (AIMCo) sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 71,700 shares — an estimated $1.29M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in SCMP in Q1 2017 and held it in 4 quarters. The position peaked at $1.29M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Alberta Investment Management Corp (AIMCo) reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 71,700 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.29M.
Alberta Investment Management Corp (AIMCo) first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2017 and held it in 4 quarters.
Alberta Investment Management Corp (AIMCo)'s Sucampo Pharmaceuticals, Inc. position peaked at $1.29M in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2018, filed 16 May 2018.